Studies related to their role in the SSc fibrotic process have shown elevated levels of serum IGF-I and IGFBP-3 in SSc patients that correlated with the extent of skin involvement and the presence of pulmonary fibrosis (196). Here, IGFBP3 is linked to systemic sclerosis.